SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-583789
Filing Date
2016-05-09
Accepted
2016-05-09 16:04:50
Documents
63
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d167293d10q.htm 10-Q 494078
2 EX-10.1 d167293dex101.htm EX-10.1 43430
3 EX-31.1 d167293dex311.htm EX-31.1 6467
4 EX-31.2 d167293dex312.htm EX-31.2 6480
5 EX-32.1 d167293dex321.htm EX-32.1 3387
6 EX-32.2 d167293dex322.htm EX-32.2 3401
13 GRAPHIC g167293ex10_1pg001.jpg GRAPHIC 11316
  Complete submission text file 0001193125-16-583789.txt   2595078

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT idra-20160331.xml EX-101.INS 416090
8 XBRL TAXONOMY EXTENSION SCHEMA idra-20160331.xsd EX-101.SCH 36577
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idra-20160331_cal.xml EX-101.CAL 50763
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idra-20160331_def.xml EX-101.DEF 95688
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20160331_lab.xml EX-101.LAB 243521
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20160331_pre.xml EX-101.PRE 169048
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 161631647
SIC: 2836 Biological Products, (No Diagnostic Substances)